Skip to main content

GO GRAY FOR A CURE 5K

Sat May 31 - Sat June 14, 2025 Suwanee, GA 30024 US

GO GRAY FOR A CURE 5K

Donation Goal: $50,000

An estimated 1 million people in the United States are living with a primary brain tumor, and approximately 94,390 more will be diagnosed this year. Glioblastoma is the most commonly occurring primary malignant brain tumor, accounting for 14.3% of all tumors and 50.1% of all malignant tumors. For malignant brain tumor patients, the five-year relative survival rate following diagnosis is 35.7%.  For the most common form of primary malignant brain tumors, glioblastoma, the five-year relative survival rate is only 6.9% and median survival is only 8 months. Pediatric brain tumors are the leading cause of cancer-related death among children and adolescents ages 0-14 years. Despite the number of brain tumors, and their devastating prognosis, there are only four FDA approved drugs and one device to treat glioblastoma. Many have and will lose their life to brain cancer this year.  Our mission is to stop that from happening by funding life-saving brain cancer research; to educate and increase awareness, and improve the quality of life for those living with brain cancer. We must find a CURE!

Join us for the fight against brain cancer and GO GRAY FOR A CURE! Help support innovative life-saving brain cancer research, increase awareness, and help more people diagnosed with brain cancer become long-term survivors.

Please send all offline donations to:

 

Go Gray for a Cure, Inc.

3651 Peachtree Parkway Ste E254

Suwanee, GA 30024

$200

Raised of $50,000

$0
$50,000

Top Donors

$200 Raised By 2 Donors

$100 in memory of Chris Doleman
$100 in memory of Chris Doleman

Select a fundraiser to donate to a cause.


Donation

Enter a custom donation amount or select a donation level above.

$
Donation Attribution

If you continue to use this site, you consent to use all cookies. We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.

If you continue to use this site, you consent to use all cookies.